BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $527,272 | +22.8% | 6,800 | +36.0% | 0.00% | 0.0% |
| Q4 2021 | $429,200 | -73.8% | 5,000 | -75.5% | 0.00% | -75.0% |
| Q3 2021 | $1,640,772 | -13.7% | 20,400 | -13.6% | 0.01% | 0.0% |
| Q2 2021 | $1,901,169 | -74.4% | 23,617 | -73.2% | 0.01% | -81.5% |
| Q1 2021 | $7,427,655 | +434.7% | 88,068 | +408.7% | 0.06% | +490.9% |
| Q4 2020 | $1,389,115 | +408.8% | 17,312 | +409.2% | 0.01% | +266.7% |
| Q3 2020 | $273,000 | -10.5% | 3,400 | -4.1% | 0.00% | 0.0% |
| Q2 2020 | $305,000 | -95.8% | 3,544 | -95.9% | 0.00% | -96.2% |
| Q1 2020 | $7,180,000 | -48.4% | 87,357 | -47.5% | 0.08% | -25.9% |
| Q4 2019 | $13,923,000 | +488.0% | 166,505 | +515.1% | 0.11% | +468.4% |
| Q3 2019 | $2,368,000 | +107.2% | 27,069 | +94.0% | 0.02% | +137.5% |
| Q2 2019 | $1,143,000 | -11.3% | 13,953 | -12.0% | 0.01% | -27.3% |
| Q1 2019 | $1,288,000 | -79.1% | 15,849 | -83.1% | 0.01% | -78.0% |
| Q4 2018 | $6,164,000 | -36.5% | 93,643 | -25.7% | 0.05% | -21.9% |
| Q3 2018 | $9,713,000 | +145.0% | 125,986 | +134.6% | 0.06% | +190.9% |
| Q2 2018 | $3,965,000 | +12.2% | 53,697 | -1.1% | 0.02% | +15.8% |
| Q1 2018 | $3,533,000 | -71.2% | 54,318 | -71.4% | 0.02% | -67.2% |
| Q4 2017 | $12,259,000 | +27.5% | 189,642 | +23.7% | 0.06% | -9.4% |
| Q3 2017 | $9,618,000 | +100.7% | 153,280 | +93.6% | 0.06% | +100.0% |
| Q2 2017 | $4,792,000 | +39.1% | 79,162 | +19.2% | 0.03% | +23.1% |
| Q1 2017 | $3,444,000 | -52.0% | 66,406 | -59.0% | 0.03% | -35.0% |
| Q4 2016 | $7,177,000 | +98.0% | 161,852 | +112.5% | 0.04% | +110.5% |
| Q3 2016 | $3,625,000 | -97.7% | 76,162 | -97.9% | 0.02% | -97.4% |
| Q2 2016 | $160,987,000 | +351.5% | 3,560,096 | +310.2% | 0.73% | +257.1% |
| Q1 2016 | $35,654,000 | +6.9% | 867,926 | -0.7% | 0.20% | +8.5% |
| Q4 2015 | $33,356,000 | +203.5% | 874,328 | +161.4% | 0.19% | +204.8% |
| Q3 2015 | $10,989,000 | +372.6% | 334,515 | +906.1% | 0.06% | +416.7% |
| Q2 2015 | $2,325,000 | -36.9% | 33,250 | -38.2% | 0.01% | -40.0% |
| Q1 2015 | $3,686,000 | -40.6% | 53,800 | -36.4% | 0.02% | -45.9% |
| Q4 2014 | $6,202,000 | +435.6% | 84,612 | +424.1% | 0.04% | +362.5% |
| Q3 2014 | $1,158,000 | -35.0% | 16,144 | -34.5% | 0.01% | -46.7% |
| Q2 2014 | $1,781,000 | +26.7% | 24,631 | +28.9% | 0.02% | +7.1% |
| Q1 2014 | $1,406,000 | -81.0% | 19,112 | -82.0% | 0.01% | -70.2% |
| Q4 2013 | $7,400,000 | -3.5% | 106,395 | -8.8% | 0.05% | -37.3% |
| Q3 2013 | $7,666,000 | -58.2% | 116,688 | -55.9% | 0.08% | -61.9% |
| Q2 2013 | $18,346,000 | – | 264,852 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |